| Literature DB >> 21490872 |
Vishnu Banumukala1, Adarsh Babu.
Abstract
A 56-year-old male was admitted with symptoms of belching, abdominal pain and weight loss of 2 weeks duration. Examination revealed hepatosplenomegaly which was confirmed by computed tomography (CT). CT images also revealed filling defects in the portal vein and intrahepatic branches consistent with thrombosis and hepatosplenic infarcts. Alkaline phosphatase was elevated at 688 units, all other investigations, including full blood count, coagulation screen and tumour markers, were normal. Magnetic resonance cholangiopancreatography did not reveal any mass in the porta hepatis. Upper gastrointestinal endoscopy and colonoscopy were normal. Liver biopsy was normal and did not reveal any evidence of lymphoma. The raised alkaline phosphatase settled to reference range over a period of 3 weeks. Thrombophilia screen was negative. Contrast CT of the abdomen performed after 4 weeks displayed revascularisation of the previously thrombosed portal vein and intrahepatic branches. The patient has remained asymptomatic since and we note spontaneous recanalisation of the previously occluded portal vein.Entities:
Keywords: Outcome; Portal vein thrombosis; Spontaneous resolution
Year: 2008 PMID: 21490872 PMCID: PMC3075200 DOI: 10.1159/000164619
Source DB: PubMed Journal: Case Rep Gastroenterol ISSN: 1662-0631
Fig. 1CT performed at initial presentation shows hypodense areas in the liver and spleen suggesting infarct.
Fig. 2Hypodense area in the liver and spleen suggesting infarct.
Fig. 3Another section through the liver demonstrating infarcts around the porta hepatis.
Fig. 4Another section through the liver and spleen.
Fig. 5CT of the liver and spleen performed 4 weeks after initial CT demonstrating resolving infarcts.
Fig. 6Another section through the liver and spleen 4 weeks later.
Fig. 7Section through the liver and spleen showing almost complete resolution of infarct in the liver.
Fig. 8MRI performed 4 weeks after initial CT also demonstrates resolution of infarcts in the liver and resolving infarcts in the spleen.